Evaluation of moringa oleifera aqueous extract for antinoCICeptive and anti-inflammatory activities in animal models

Pharmaceutical Biology

Volumn 46, Issue 12, 2008, Pages 838-845

  Sulaiman, M R ^a   Zakaria, Z A ^b   Bujarimin, A S ^a   Somchit, M N ^a   Israf, D A ^a   Moin, S ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

anti inflammatory activity; antinociceptive activity; aqueous extract; dose independent; Moringa oleifera; opioid mediated

Indexed keywords

EID: 72549100271     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802366710     Document Type: Article

References (38)

1. Amanlou M, Dadkhah F, Salehnia A, Farsam H, Dehpour AR (2005): Anti-inflammatory and anti-nociceptive effects of hydrochloric extract of Satureja khuzistanica Jamzad extract. J Pharm Pharmaceut Sci 8: 102-106. (Pubitemid 41528875)
2. Anwar F, Latif S, Ashraf M, Gilani AH (2007): Moringa oleifera: A food plant with multiple medicinal uses. Phytother Res 21: 17-25. (Pubitemid 46173903)
3. Bentley GA, Newton SH, Starr J (1983): Studies on the antinociceptive action of α-agonist drugs and their interactions with opioid mechanisms. Br J Pharmacol 79: 125-134. (Pubitemid 13128980)
4. BharaliR,Tabassum J, AzadMR(2003):Chemomodulatory effect of Moringa oleifera Lam. on hepatic carcinogen metabolizing enzymes, antioxidant parameters and skin papilomagenesis in mice. Asian Pac J Cancer Prev 4: 131-139.
5. Caceres A, Cabrera O, Morales O,Mollinedo P,Mendia P (1991): Pharmaoclogical properties of Moringa oleifera. 1: Preliminary screening for antimicrobial activity. J Ethnopharmacol 33: 213-216.
6. Caceres A, Saravia A, Rizzo S, Zabala L, De Leon E, Nave F (1992): Pharmaoclogical properties of Moringa oleifera. 2: Screening for antispasmodic, anti-inflammatory and diuretic activity. J Ethnopharmacol 36: 233-247.
7. Chan TF, Tsai HY, Tian-ShangW(1995): Anti-inflammatory and analgesic activities from the roots of Angelica pubescens. Planta Med 61: 2-8.
8. Chen CK, Pace-AsciakCR(1996):Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27: 363-366. (Pubitemid 26129194)
9. Collier HOJ, Dinneen LC, Jhonson CA, Schneider C (1968): The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32: 295-310.
10. Dambisya YM, Lee T-L (1995): Effects of L-N(G)-nitro arginine methyl ester (L-NAME), L-N(G)-monomethyl arginine (L-NMMA) and L-arginine on the antinociceptive effects of morphine in mice. Method Find Exp Clin 17: 577-582.
11. EddyNB, LeimbachD(1953): Synthesis analgesics, II: Dithienylbutenyl and dithienylbutenylamines. J Pharmacol Exp Ther 107: 385-393.
12. Ferreira SH, Duarte IDG, Lorenzetti BB (1991): The molecular mechanism of action of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 201: 121-122.
13. Gamache DA, Povlishock JT, Ellis EF (1986): Carrageenaninduced brain inflammation. Characterization of the model. J Neurosurg 65: 675-685.
14. Hosseinzadeh H, Younesi HM (2002): Antinociceptive and antiinflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2: 7.
15. Hunskaar S, Hole K (1987): The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-104.
16. Katzung BG (2005): Basic and clinical pharmacology, 6th ed. Connecticut, Appleton and Lange, pp. 297-302.
17. KimHP, Son KH, ChangHW, Kang SS (2004):Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96: 229-245. (Pubitemid 40013328)
18. Machelska H, Labuz D, Przewlocki R, Przewlocka B (1997): Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 282: 977-984. (Pubitemid 27340203)
19. Manguro LO, Lemmen P (2007): Phenolics of Moringa oleifera leaves. Nat Prod Res 21: 56-68. (Pubitemid 46322953)
20. Marieb EN (2000): Human Anatomy and Physiology, 5th ed. San Francisco, Benjamin-Cummings, pp. 761-764.
21. Meotti FC, Luiz AP, Pizzolatti MG, Kassuya CAL, Calixto JB, Santos ARS (2005): Analysis of the antinociceptive effect of the flavonoidmyricitrin. Evidence for a role of the L-argininenitric oxide and protein kinase C pathways. J Pharmacol Exp Ther 316:789-796.
22. Middleton E Jr, Kandaswami C, Theoharides TC (2000): The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
23. Nam NH (2006): Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6: 945-951.
24. Naseri MKG, Hamidi MN, Heidari A (2005): Vasorelaxatory effect of Vitis vinifera extract on rat aorta. Iran J Pharmaceut Sci 2: 93-99.
25. Ndiaye M, DieyeAM, Mariko F, Tall A, Sall Diallo, FayeB(2002): Contribution to the study of the anti-inflammatory activity of Moringa oleifera (Moringaceae). Dakar Med 47: 210-212.
26. Oblak M, Randic M, Solmajer T (2000): Quantitative structureactivity relationship of flavonoid analogues. 3. Inhibition of p56lck protein tyrosine kinase. J Chem Inf Comput Sci 40: 994-1001.
27. Olszanecki R, Gêbska A, Kozlovski VI, Gryglewski RJ (2002): Flavonoids and nitric oxide synthase. J Physiol Pharmacol 53: 571-584. (Pubitemid 36014803)
28. Pini LA, Vitale G, Ottani A, Sandrini M (1997): Naloxonereversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 280: 934-940.
29. Rathi BS, Bodhankar SL, BahetyiAM(2006): Evaluation of aqueous extract of Moringa oleifera Linn for wound healing in albino rats. Indian J Exp Biol 44: 898-901. (Pubitemid 44736229)
30. Robak J, Shridi F,WolbisM, KrolikowskaM(1998): Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation. Pol J Pharmacol Pharm 40: 451-458.
31. Santos ARS, Filho VC, Niero R, Viana AM, Morenof N, Campos MM, Yunes RA, Calixto JB (1994): Analgesic effects of callus culture extracts from selected species of Phyllantus in mice. J Pharm Pharmacol 46: 755-759. (Pubitemid 24289666)
32. Shibata M, Ohkubo T, Takahashi H, Inoki R (1989): Modified formalin test: Characteristic biphasic pain response. Pain 38(3): 347-352. (Pubitemid 19251258)
33. Sulaiman MR, Somchit MN, Israf DA, Ahmad Z, Moin S (2004): Antinociceptive effect of Melastoma malabathricum ethanolic extract in mice. Fitoterapia 75: 667-672. (Pubitemid 39573464)
34. Tj'lsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992): The formalin test: An evaluation of the method. Pain 51: 5-17.
35. Uzcátegui B, Ávila D, Suárez-Roca H, Quintero L, Ortega J, González B (2004): Anti-inflammatory, antinociceptive, and antipyretic effects of Lantana trifolia Linnaeus in experimental animals. Invest Clín 45: 317-322. (Pubitemid 39647940)
36. Winter CA, Risley EA, Nuss GW (1962): Carrageenan-induced edema in hind pawof the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111: 544-547.
37. Zakaria ZA, Safarul M, Valsala R, Sulaiman MR, Fatimah CA, Mat Jais AM(2005): Influence of temperature on the opioidmediated antinociceptive activity of Corchorus olitorius L. in mice. Naunyn-Schmiedeberg's Arch Pharmacol 372: 55-62. (Pubitemid 41414045)
38. Zimmermann M (1983): Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16: 109-110. (Pubitemid 13058546)